8-K - United Therapeutics Corporation | StockGist

Current Report Details

Event Type

Regulation Fd

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

. Regulation FD Disclosure On March 2, 2026, United Therapeutics Corporation (the “ Company ”) issued a press release announcing positive results of the ADVANCE

Regulation Fd

9.01

. Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Presentation dated March 2, 2026 99.2 Investor Presentation dated March 2, 2026 104 The co

Exhibits Only

Exhibits (3)

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2